217 related articles for article (PubMed ID: 30298050)
1. 3-Iodothyronamine Activates a Set of Membrane Proteins in Murine Hypothalamic Cell Lines.
Bräunig J; Mergler S; Jyrch S; Hoefig CS; Rosowski M; Mittag J; Biebermann H; Khajavi N
Front Endocrinol (Lausanne); 2018; 9():523. PubMed ID: 30298050
[TBL] [Abstract][Full Text] [Related]
2. 3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8?
Khajavi N; Mergler S; Biebermann H
Front Endocrinol (Lausanne); 2017; 8():198. PubMed ID: 28861042
[TBL] [Abstract][Full Text] [Related]
3. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
[TBL] [Abstract][Full Text] [Related]
4. Vascular Endothelial Growth Factor (VEGF) Induced Downstream Responses to Transient Receptor Potential Vanilloid 1 (TRPV1) and 3-Iodothyronamine (3-T
Türker E; Garreis F; Khajavi N; Reinach PS; Joshi P; Brockmann T; Lucius A; Ljubojevic N; Turan E; Cooper D; Schick F; Reinholz R; Pleyer U; Köhrle J; Mergler S
Front Endocrinol (Lausanne); 2018; 9():670. PubMed ID: 30524369
[TBL] [Abstract][Full Text] [Related]
5. TRPM8 Activation via 3-Iodothyronamine Blunts VEGF-Induced Transactivation of TRPV1 in Human Uveal Melanoma Cells.
Walcher L; Budde C; Böhm A; Reinach PS; Dhandapani P; Ljubojevic N; Schweiger MW; von der Waydbrink H; Reimers I; Köhrle J; Mergler S
Front Pharmacol; 2018; 9():1234. PubMed ID: 30483120
[TBL] [Abstract][Full Text] [Related]
6. Thyronamine induces TRPM8 channel activation in human conjunctival epithelial cells.
Khajavi N; Reinach PS; Slavi N; Skrzypski M; Lucius A; Strauß O; Köhrle J; Mergler S
Cell Signal; 2015 Feb; 27(2):315-25. PubMed ID: 25460045
[TBL] [Abstract][Full Text] [Related]
7. 3-Iodothyronamine Decreases Expression of Genes Involved in Iodide Metabolism in Mouse Thyroids and Inhibits Iodide Uptake in PCCL3 Thyrocytes.
Schanze N; Jacobi SF; Rijntjes E; Mergler S; Del Olmo M; Hoefig CS; Khajavi N; Lehmphul I; Biebermann H; Mittag J; Köhrle J
Thyroid; 2017 Jan; 27(1):11-22. PubMed ID: 27788620
[TBL] [Abstract][Full Text] [Related]
8. The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling.
Dinter J; Khajavi N; Mühlhaus J; Wienchol CL; Cöster M; Hermsdorf T; Stäubert C; Köhrle J; Schöneberg T; Kleinau G; Mergler S; Biebermann H
Eur Thyroid J; 2015 Sep; 4(Suppl 1):21-9. PubMed ID: 26601070
[TBL] [Abstract][Full Text] [Related]
9. 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.
Dinter J; Mühlhaus J; Jacobi SF; Wienchol CL; Cöster M; Meister J; Hoefig CS; Müller A; Köhrle J; Grüters A; Krude H; Mittag J; Schöneberg T; Kleinau G; Biebermann H
J Mol Endocrinol; 2015 Jun; 54(3):205-16. PubMed ID: 25878061
[TBL] [Abstract][Full Text] [Related]
10. 3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors.
Biebermann H; Kleinau G
Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):395-400. PubMed ID: 31698479
[TBL] [Abstract][Full Text] [Related]
11. Update on 3-iodothyronamine and its neurological and metabolic actions.
Zucchi R; Accorroni A; Chiellini G
Front Physiol; 2014; 5():402. PubMed ID: 25360120
[TBL] [Abstract][Full Text] [Related]
12. 3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism.
Lehmphul I; Hoefig CS; Köhrle J
Mol Cell Endocrinol; 2018 Jan; 460():219-228. PubMed ID: 28754352
[TBL] [Abstract][Full Text] [Related]
13. 3-Iodothyronamine Induces Tail Vasodilation Through Central Action in Male Mice.
Gachkar S; Oelkrug R; Martinez-Sanchez N; Rial-Pensado E; Warner A; Hoefig CS; López M; Mittag J
Endocrinology; 2017 Jun; 158(6):1977-1984. PubMed ID: 28368510
[TBL] [Abstract][Full Text] [Related]
14. 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice.
Manni ME; De Siena G; Saba A; Marchini M; Dicembrini I; Bigagli E; Cinci L; Lodovici M; Chiellini G; Zucchi R; Raimondi L
Br J Pharmacol; 2012 May; 166(2):650-8. PubMed ID: 22225569
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold.
Manni ME; De Siena G; Saba A; Marchini M; Landucci E; Gerace E; Zazzeri M; Musilli C; Pellegrini-Giampietro D; Matucci R; Zucchi R; Raimondi L
Br J Pharmacol; 2013 Jan; 168(2):354-62. PubMed ID: 22889145
[TBL] [Abstract][Full Text] [Related]
16. Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions.
Hoefig CS; Zucchi R; Köhrle J
Thyroid; 2016 Dec; 26(12):1656-1673. PubMed ID: 27650974
[TBL] [Abstract][Full Text] [Related]
17. Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5.
Dinter J; Mühlhaus J; Wienchol CL; Yi CX; Nürnberg D; Morin S; Grüters A; Köhrle J; Schöneberg T; Tschöp M; Krude H; Kleinau G; Biebermann H
PLoS One; 2015; 10(2):e0117774. PubMed ID: 25706283
[TBL] [Abstract][Full Text] [Related]
18. Determination of 3-iodothyronamine (3-T
Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577
[TBL] [Abstract][Full Text] [Related]
19. The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection.
Laurino A; Gencarelli M; Raimondi L
Eur J Pharmacol; 2021 Dec; 912():174606. PubMed ID: 34717926
[TBL] [Abstract][Full Text] [Related]
20. Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases.
Laurino A; Landucci E; Raimondi L
Front Endocrinol (Lausanne); 2018; 9():290. PubMed ID: 29928258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
